Bienox is BNC Korea’s botulinum toxin type A, a vacuum-dried toxin that received Korea MFDS approval in 2024, supplied as a 100 U vial and reconstituted with preservative-free saline before injection. BNC Korea has no FDA-approved toxin, so no FDA status is claimed. Potency units are product-specific. Professional use only.
What is Bienox?
Bienox is BNC Korea’s botulinum toxin type A, a newer Korean toxin that received MFDS manufacturing and marketing approval in 2024. It is a vacuum-dried preparation, supplied as a 100 U vial and reconstituted with preservative-free saline before injection. Potency units are specific to this product and are not interchangeable with other botulinum toxin products.
How does Bienox compare with other Korean toxins?
Bienox is vacuum-dried, like Nabota and Metox, rather than freeze-dried. It is one of the more recently approved Korean toxins.
| Bienox | BNC Korea · vacuum-dried · 100 U |
|---|---|
| Nabota | Daewoong · vacuum-dried · 100/200 U |
| Metox | Maypharm · vacuum-dried · 100/200 U |
What do clinics use Bienox for?
Clinics select Bienox for facial expression-line work per the manufacturer’s labelling. Dosing and technique are product-specific and decided by the treating clinician; units are not interchangeable with other toxins.
Commonly selected for
- Clinics preferring a vacuum-dried toxin
- Practices trying a newer Korean unit
- Single-vial 100 U caseloads
- Aesthetic expression-line protocols
How is Bienox supplied?
One 100 U vacuum-dried single-use vial. Supplied vacuum-dried; reconstitute with preservative-free 0.9% sodium chloride before use. Reconstitute immediately before use and follow the manufacturer’s handling instructions.
Reviewed against publicly available manufacturer information. Indications, dosing and technique are product-specific per the manufacturer’s labeling and are decided by the treating clinician.
Specifications
| Brand | Bienox (BNC Korea) |
|---|---|
| Manufacturer | BNC Korea, Inc. (South Korea) |
| Origin | South Korea |
| Active | Botulinum toxin type A (100 U) |
| Composition | Clostridium botulinum type A toxin; supplied vacuum-dried |
| Units | 100 U |
| Format | 100 U vacuum-dried single-use vial |
| Areas | Facial expression lines (aesthetic use) |
| Delivery | Reconstitute with preservative-free 0.9% saline; inject intramuscularly per the practitioner’s protocol |
| Regulatory | Received Korea MFDS manufacturing and marketing approval in 2024. Its maker, BNC Korea, does not have an FDA-approved botulinum toxin product, so no FDA status is claimed. |
| Administration | Injectable — by a qualified medical professional only |
| Storage & handling | Store refrigerated (2–8 °C) per the manufacturer’s instructions. |
Frequently asked questions
Who makes Bienox?
BNC Korea, Inc. in South Korea. It received MFDS manufacturing and marketing approval in 2024.
Is Bienox freeze-dried?
No. Bienox is vacuum-dried and reconstituted with preservative-free saline before use.
Is Bienox FDA-approved?
No. BNC Korea does not have an FDA-approved botulinum toxin product.
How is it supplied?
As one vacuum-dried 100 U single-use vial, reconstituted with preservative-free 0.9% saline before use.
Are its units interchangeable with other toxins?
No. Potency units are specific to this product and are not converted 1:1 to other botulinum toxin products.